MeMed: Ori Hadomi, Peter Scheu, Scott Garrett
MeMed has appointed Ori Hadomi as chairman of the board of directors and Scott Garrett as a member of the board. The company has also named Peter Scheu as president of MeMed US.
Hadomi currently serves as VP of strategic initiatives and partnerships at Medtronic. Previously, he was CEO at Mazor Robotics, which was later acquired by Medtronic. Garrett is currently a senior operating partner at healthcare-focused private equity firm Water Street Healthcare Partners. Prior to that, he was president and CEO of Beckman Coulter. Scheu was previously president of North American commercial operations at LumiraDx. Before that, he was president of North American commercial operations at Alere, as well as president of anatomical pathology at Thermo Fisher Scientific.